Definition
A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
Top Gene Interactions
Related Pathways
Chlorzoxazone Interacts with Diseases
Disease | Inference Score | References/Inference Genes |
Diabetes Mellitus, Type 2 | 12.53 | |
Neural Tube Defects | 10.84 |
|
Cardiac hypertrophy | 8.87 |
|
Obesity | 8.67 |
References/Inference Genes
|
Prostatic Neoplasms | 8.41 | |
Liver Cirrhosis, Experimental | 7.51 |
|
Chronic obstructive pulmonary disease | 7.38 |
|
Acute lymphoblastic leukemia | 6.96 |
|
Drug-Related Side Effects and Adverse Reactions | 6.6 |
References/Inference Genes
|
Lung Injury | 6.56 |
|
Methemoglobinemia Type IV | 6.54 |
|
Drug-induced liver injury | 6.46 | |
Reperfusion Injury | 6.46 |
|
Micronuclei, Chromosome-Defective | 6.27 |
|
Xanthinuria, Type I | 6.23 |
|
Diabetes Mellitus, Insulin-Dependent, 2 | 6.12 |
|
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10 | 6.12 |
|
Parkinson's disease | 5.91 |
|
Maturity-Onset Diabetes of the Young, Type 1 | 5.78 |
|
Telomeric 22q13 Monosomy Syndrome | 5.78 |
|